All News #Library
Biotech
Curateq Biologics Reports Phase 3 Results for BP11
07 Apr 2026 //
EXPRESSPHARMA
Aurobindo`s Unit Receive UK Approval for Biosimilar Breast Cancer
27 Aug 2025 //
BUSINESS STD
Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
14 May 2025 //
THEHINDU
CuraTeQ Biologics gets positive opinion for Dazublys biosimilar
28 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar
09 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
03 Feb 2025 //
INDPHARMAPOST

Market Place
Sourcing Support